Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status

Epidermal growth factor receptor tyrosine-kinase inhibitors (EGFR-TKIs) are standard treatment for advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation. However, EGFR mutation testing is not attainable in approximately 20% of patients. The curren...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Jian, Hong, Li, Wei, Ma, Zhiyong, Huang, Jianjin, Feng, Jifeng, Song, Yong, Gao, Beili, Zhu, Huili, Tao, Min, Bai, Chong, Ma, Shenglin, Pan, Hongming, Qin, Shukui, Hua, Dong, Yu, Yongfeng, Lu, Shun
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5559626/
https://ncbi.nlm.nih.gov/pubmed/28814805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-08399-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados